Literature DB >> 18309006

Viral infection after renal transplantation: surveillance and management.

Blair C Weikert1, Emily A Blumberg.   

Abstract

Viral infections remain a significant cause of morbidity and mortality following renal transplantation. Although cytomegalovirus is the most common opportunistic pathogen seen in transplant recipients, numerous other viruses have also affected outcomes. In some cases, preventive measures such as pretransplant screening, prophylactic antiviral therapy, or post transplant viral monitoring may limit the impact of these infections. Recent advances in laboratory monitoring and antiviral therapy have improved outcomes. This review will summarize the major viral infections seen following transplant and discuss strategies for prevention and management of these potential pathogens.

Entities:  

Mesh:

Substances:

Year:  2008        PMID: 18309006      PMCID: PMC3152274          DOI: 10.2215/CJN.02900707

Source DB:  PubMed          Journal:  Clin J Am Soc Nephrol        ISSN: 1555-9041            Impact factor:   8.237


  100 in total

1.  Adenovirus infections in transplant recipients.

Authors:  Michael G Ison
Journal:  Clin Infect Dis       Date:  2006-06-19       Impact factor: 9.079

Review 2.  BK virus infection in transplant recipients: an overview and update.

Authors:  P Randhawa; D C Brennan
Journal:  Am J Transplant       Date:  2006-06-09       Impact factor: 8.086

3.  The natural course of cytomegalovirus infection and disease in renal transplant recipients.

Authors:  Anders Hartmann; Solbjørg Sagedal; Jøran Hjelmesaeth
Journal:  Transplantation       Date:  2006-07-27       Impact factor: 4.939

Review 4.  Polyomavirus-associated nephropathy: update on antiviral strategies.

Authors:  M A Josephson; J W Williams; A Chandraker; P S Randhawa
Journal:  Transpl Infect Dis       Date:  2006-06       Impact factor: 2.228

5.  HIV-positive renal recipients can achieve survival rates similar to those of HIV-negative patients.

Authors:  Jianxin Qiu; Paul I Terasaki; Kayo Waki; Junchao Cai; David W Gjertson
Journal:  Transplantation       Date:  2006-06-27       Impact factor: 4.939

6.  CMV-IVIG for prevention of Epstein Barr virus disease and posttransplant lymphoproliferative disease in pediatric liver transplant recipients.

Authors:  M Green; M G Michaels; B Z Katz; M Burroughs; D Gerber; B L Shneider; K Newell; D Rowe; J Reyes
Journal:  Am J Transplant       Date:  2006-08       Impact factor: 8.086

7.  Disassociation between risk of graft loss and risk of non-Hodgkin lymphoma with induction agents in renal transplant recipients.

Authors:  Gerhard Opelz; Cord Naujokat; Volker Daniel; Peter Terness; Bernd Döhler
Journal:  Transplantation       Date:  2006-05-15       Impact factor: 4.939

Review 8.  Rituximab, an anti-cd20 monoclonal antibody: history and mechanism of action.

Authors:  M D Pescovitz
Journal:  Am J Transplant       Date:  2006-05       Impact factor: 8.086

9.  Thymoglobulin-associated Cd4+ T-cell depletion and infection risk in HIV-infected renal transplant recipients.

Authors:  J T Carter; M L Melcher; L L Carlson; M E Roland; P G Stock
Journal:  Am J Transplant       Date:  2006-04       Impact factor: 8.086

10.  Antibody response to hepatitis B vaccine in end-stage renal disease patients.

Authors:  Kai Ming Chow; Man Ching Law; Chi Bon Leung; Cheuk Chun Szeto; Philip Kam-Tao Li
Journal:  Nephron Clin Pract       Date:  2006-03-13
View more
  28 in total

1.  Hospital-onset Clostridium difficile infection among solid organ transplant recipients.

Authors:  J P Donnelly; H E Wang; J E Locke; R B Mannon; M M Safford; J W Baddley
Journal:  Am J Transplant       Date:  2015-11       Impact factor: 8.086

2.  Relationship Among Viremia/Viral Infection, Alloimmunity, and Nutritional Parameters in the First Year After Pediatric Kidney Transplantation.

Authors:  R Ettenger; H Chin; K Kesler; N Bridges; P Grimm; E F Reed; M Sarwal; R Sibley; E Tsai; B Warshaw; A D Kirk
Journal:  Am J Transplant       Date:  2017-02-01       Impact factor: 8.086

3.  Temporal virus serological profiling of kidney graft recipients using VirScan.

Authors:  Pierre Isnard; Tomasz Kula; Véronique Avettand Fenoel; Dany Anglicheau; Fabiola Terzi; Christophe Legendre; Stephen J Elledge; Guillaume Canaud
Journal:  Proc Natl Acad Sci U S A       Date:  2019-05-13       Impact factor: 11.205

4.  Immunogenicity of Four Doses of Double-Strength Intramuscular Hepatitis B.

Authors:  Seyed Ali Asghar Fakhrmousavi; Azar Hadadi; Seyed Hamed Hosseini; Maryam Rahbar; Reza Hamidian; Amitis Ramezani; Gholamreza Pourmand; Effat Razeghi
Journal:  Iran J Pathol       Date:  2016

Review 5.  Immunosuppressive drugs in kidney transplantation: impact on patient survival, and incidence of cardiovascular disease, malignancy and infection.

Authors:  Roberto Marcén
Journal:  Drugs       Date:  2009-11-12       Impact factor: 9.546

6.  [Fever, coughing and dyspnea in a 38-year-old female kidney transplant recipient].

Authors:  M Porsche; E Künzli; M Dickenmann; H H Hirsch; M Battegay; N Khanna
Journal:  Internist (Berl)       Date:  2012-12       Impact factor: 0.743

7.  Viral infection causes a shift in the self peptide repertoire presented by human MHC class I molecules.

Authors:  Charles T Spencer; Jelena S Bezbradica; Mireya G Ramos; Chenoa D Arico; Stephanie B Conant; Pavlo Gilchuk; Jennifer J Gray; Mu Zheng; Xinnan Niu; William Hildebrand; Andrew J Link; Sebastian Joyce
Journal:  Proteomics Clin Appl       Date:  2015-12       Impact factor: 3.494

8.  Inpatient Mortality Among Solid Organ Transplant Recipients Hospitalized for Sepsis and Severe Sepsis.

Authors:  John P Donnelly; Jayme E Locke; Paul A MacLennan; Gerald McGwin; Roslyn B Mannon; Monika M Safford; John W Baddley; Paul Muntner; Henry E Wang
Journal:  Clin Infect Dis       Date:  2016-05-23       Impact factor: 9.079

9.  CMV, EBV, JCV and BKV infection and outcome following kidney transplantation in children initiated on a corticosteroid-minimisation immunosuppressive regimen.

Authors:  James McCaffrey; Vijesh J Bhute; Mohan Shenoy
Journal:  Pediatr Nephrol       Date:  2021-04-06       Impact factor: 3.714

10.  A three year Seroepidemiological and molecular study of Epstein -Barr virus infection among different age groups with hematological malignancies in a Tertiary care centre of North India ( 2017 -2019).

Authors:  Sangram Singh Patel; Sweta Singh; Chinmoy Sahu; Ujjala Ghoshal; Hemant Verma
Journal:  J Family Med Prim Care       Date:  2021-01-30
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.